Compare AUBN & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUBN | MNOV |
|---|---|---|
| Founded | 1907 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.8M | 72.7M |
| IPO Year | 1996 | 2004 |
| Metric | AUBN | MNOV |
|---|---|---|
| Price | $24.74 | $1.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 889.0 | ★ 61.5K |
| Earning Date | 04-28-2026 | 06-08-2026 |
| Dividend Yield | ★ 4.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | $614,000.00 | ★ $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.59 | ★ N/A |
| Revenue Growth | 1.82 | ★ 194.15 |
| 52 Week Low | $19.00 | $1.13 |
| 52 Week High | $29.00 | $1.96 |
| Indicator | AUBN | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 39.64 |
| Support Level | $23.93 | $1.23 |
| Resistance Level | $25.54 | $1.38 |
| Average True Range (ATR) | 0.33 | 0.10 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 37.65 | 15.00 |
Auburn National Bancorp Inc operates as a bank holding company, which offers checking, savings, transaction deposit accounts and certificates of deposit, and is an active residential mortgage lender in its primary service area. The Bank's primary service area includes the cities of Auburn and Opelika, Alabama and nearby surrounding areas in East Alabama, predominantly in Lee County. The Bank also offers commercial, financial, agricultural, real estate construction and consumer loan products and other financial services. The Bank also provides automated teller machine (ATM) services in East Alabama and operates ATM machines. The Bank offers Visa Checkcards, which are debit cards. The Bank offers online banking, bill payment and other electronic banking services through its Internet website.
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.